These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9550836)

  • 1. [Left ventricular hypertrophy; differences in diagnostic and prognostic value of electrocardiography and echocardiography].
    Beltman FW
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2363-4. PubMed ID: 9550836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular repolarization in hypertension: beyond Bazett.
    Passino C; Emdin M
    Am J Hypertens; 2008 Jan; 21(1):9. PubMed ID: 18091736
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-drug therapy and reduction of left ventricular mass in hypertension.
    Gottdiener JS
    Cardiologia; 1998 Nov; 43(11):1177-83. PubMed ID: 9922583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophy.
    Rosei EA
    Blood Press; 2003; 12(3):183-4. PubMed ID: 12875482
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 9. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
    J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular hypertrophy and hypertension.
    Katibi IA
    Niger J Med; 2004; 13(1):8-17. PubMed ID: 15296101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower heart rates for healthy hearts: time to redefine tachycardia?
    Gopinathannair R; Sullivan RM; Olshansky B
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):321-3. PubMed ID: 19808425
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlling blood pressure by centrally acting drugs--still a topic?].
    Steckelings UM; Unger T
    Fortschr Med; 1994 Jan; 112(3):25-6. PubMed ID: 8144121
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular hypertrophy: pathogenesis, diagnosis and therapy].
    Nagy V
    Orv Hetil; 2001 Jul; 142(26):1375-83. PubMed ID: 11478033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.